The WHO published reports highlighting the critical lack of medicines and diagnostic tools for invasive fungal diseases, emphasizing the need for innovative R&D. With common infections becoming resistant to treatment, severely ill patients and those with weakened immune systems are disproportionately affected. The reports underscore the urgent need for safer antifungal medicines, improved diagnostics, and increased global investment in research and development to address the growing threat of invasive fungal diseases.
Full Article
Loading PerspectiveSplit analysis...
